circ-LDLRAD3 Knockdown Reduces Cisplatin Chemoresistance and Inhibits the Development of Gastric Cancer with Cisplatin Resistance through miR-588 Enrichment-Mediated SOX5 Inhibition

BACKGROUND/AIMS: Chemoresistance is a common event after cancer chemotherapy, which is associated with the deregulation of circular RNAs (circRNAs). The objective of this study was to clarify the role of circ-LDLRAD3 in cisplatin (DDP)-resistant gastric cancer (GC). METHODS: The expression of circ-L...

Descripción completa

Detalles Bibliográficos
Autores principales: Liang, Qianping, Chu, Feifei, Zhang, Lei, Jiang, Yuanyuan, Li, Lu, Wu, Huili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191788/
https://www.ncbi.nlm.nih.gov/pubmed/35975639
http://dx.doi.org/10.5009/gnl210195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191788/
https://www.ncbi.nlm.nih.gov/pubmed/35975639
http://dx.doi.org/10.5009/gnl210195

Ejemplares similares